Pulmonary hypertension
Pulmonary hypertension, or PH, is a serious condition in which the pressure inside the lung vessels is above normal. MedlinePlus says it may arise by itself or as a result of another condition, such as left-sided heart failure, and that there are different types based on what caused it, including pulmonary arterial hypertension. It lists chest pain or pressure, shortness of breath, and dizziness that may lead to fainting among the symptoms, and says there is often no cure, although treatment can ease the symptoms.
Also called PH
- Condition
- In this atlas
Overview
Technical summary
MeSH D006976 is named Hypertension, Pulmonary; its scope note describes increased vascular resistance in the pulmonary circulation, usually secondary to heart or lung diseases. This record is about high pressure in the lung arteries, not the blood pressure measured in the arm.
Recognition
MedlinePlus says the symptoms are sometimes hard to recognize, so it can take years to get a diagnosis.
Burden
No burden claims are published.
Claims and evidence
Context People with deep vein thrombosis, pulmonary embolism, peripheral artery disease or pulmonary hypertension, as described in MedlinePlus and NHLBI patient pages
- Recipient
- Recipient not specified
- Population
- People with the condition each page covers. The pages give no age limits and no inclusion criteria.
- Care setting
- Not stated; patient information pages
- Geography
- Not stated; United States federal health agencies (NLM and NIH)
- Life stage
- Not stated on the pages
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (descriptive pages)
Eligibility: inclusion criteria not stated; exclusion criteria not stated
- Included
- None stated
- Excluded
- None stated
MedlinePlus describes pulmonary hypertension as a serious disorder of the lung vessels in which the pressure inside them is above normal, for example when the pulmonary arteries are damaged, narrowed or blocked. It says the disorder may arise by itself or from another condition, such as left-sided heart failure, and that there is often no cure, although treatment can ease symptoms. NHLBI says it increases the work the heart does to send blood to the lungs.
Applies to Recipient not specified People with deep vein thrombosis, pulmonary embolism, peripheral artery disease or pulmonary hypertension, as described in MedlinePlus and NHLBI patient pages
- Certainty method
- Not assessed
- Limitations
- Patient-education pages from US government sources. They give no study, no size of risk and no population, and they do not say how often any of this happens. The pages describe lung blood pressure, not the blood pressure measured in the arm.
- Last checked
- 2026-10-30
- Next evidence check due
- Not scheduled
Sources and citations (8)
-
Supports Pulmonary Hypertension (MedlinePlus health topic)
- Locator
- What is pulmonary hypertension?, paragraph 1, sentence 1
- How it applies
- MedlinePlus: what the condition is.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
25f50e785cf52e29bca0ff8871800a088148f9f83265f6b327951b83f37a0fda- Reuse basis
- MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source (MedlinePlus using-content page, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161, hash only). Some images on MedlinePlus are copyrighted; this atlas uses none. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Pulmonary Hypertension (MedlinePlus health topic)
- Locator
- What is pulmonary hypertension?, paragraph 1, sentence 2
- How it applies
- MedlinePlus: lung blood pressure higher than normal.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
25f50e785cf52e29bca0ff8871800a088148f9f83265f6b327951b83f37a0fda- Reuse basis
- MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source (MedlinePlus using-content page, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161, hash only). Some images on MedlinePlus are copyrighted; this atlas uses none. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Pulmonary Hypertension (MedlinePlus health topic)
- Locator
- What is pulmonary hypertension?, paragraph 3, sentence 2
- How it applies
- MedlinePlus: damaged, narrowed or blocked pulmonary arteries.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
25f50e785cf52e29bca0ff8871800a088148f9f83265f6b327951b83f37a0fda- Reuse basis
- MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source (MedlinePlus using-content page, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161, hash only). Some images on MedlinePlus are copyrighted; this atlas uses none. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Pulmonary Hypertension (MedlinePlus health topic)
- Locator
- What causes pulmonary hypertension?, paragraph 1, sentence 1
- How it applies
- MedlinePlus: on its own or from another condition.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
25f50e785cf52e29bca0ff8871800a088148f9f83265f6b327951b83f37a0fda- Reuse basis
- MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source (MedlinePlus using-content page, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161, hash only). Some images on MedlinePlus are copyrighted; this atlas uses none. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Pulmonary Hypertension (MedlinePlus health topic)
- Locator
- What causes pulmonary hypertension?, list item 1
- How it applies
- MedlinePlus: heart diseases are one cause.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
25f50e785cf52e29bca0ff8871800a088148f9f83265f6b327951b83f37a0fda- Reuse basis
- MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source (MedlinePlus using-content page, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161, hash only). Some images on MedlinePlus are copyrighted; this atlas uses none. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Pulmonary Hypertension (MedlinePlus health topic)
- Locator
- What are the treatments for pulmonary hypertension?, paragraph 1, sentence 1
- How it applies
- MedlinePlus: often no cure, treatment helps manage symptoms.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
25f50e785cf52e29bca0ff8871800a088148f9f83265f6b327951b83f37a0fda- Reuse basis
- MedlinePlus says its summaries on health topic pages are in the public domain and asks users to acknowledge MedlinePlus as the source (MedlinePlus using-content page, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161, hash only). Some images on MedlinePlus are copyrighted; this atlas uses none. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Pulmonary Hypertension: What Is Pulmonary Hypertension? (NHLBI)
- Locator
- What Is Pulmonary Hypertension?, paragraph 1
- How it applies
- NHLBI: the heart works harder. Last updated May 01, 2023 according to the page.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
98fd71a76fdb8f2f17300792080a72f854e2b80953ac5c23501dcf46efa92b8b- Reuse basis
- NHLBI is part of the U.S. National Institutes of Health. The pages carry third-party material, such as animations credited to Nucleus Medical Media, that this atlas does not use. NHLBI's own reuse terms were not read, so public text is cite_only until they are read; the rule can then change to quote. Hash only; the page is not committed.
-
Background MeSH scope note for descriptor D006976 (Hypertension, Pulmonary)
- Locator
- scopeNote.@value
- How it applies
- MeSH scope note for pulmonary hypertension.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
5f579e85e9399e7792fbe8984f0181e77c751383a6952b63edd876d34f4290a5- Reuse basis
- The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-10-30 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
Clinical links
Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.
-
Claim, not a settled fact Evaluated for this: Riociguat
Applies to Adult Adults with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension, as described in the US label of Adempas
Population, setting and follow-up
- Adults with persistent or recurrent chronic thromboembolic pulmonary hypertension after surgical treatment, or inoperable disease (WHO Group 4), and adults with pulmonary arterial hypertension (WHO Group 1), as the label states.
- Prescription medicine, as described in the US label
- United States (label of the US Food and Drug Administration)
- Adults, as the label states
The US label of Adempas (riociguat tablets, Bayer HealthCare Pharmaceuticals Inc., application NDA204819; the version dated 2026-08-13 in openFDA) describes riociguat as a soluble guanylate cyclase stimulator. It lists treating adults with persistent or recurrent chronic thromboembolic pulmonary hypertension (WHO Group 4) after surgical treatment, or inoperable disease, and adults with pulmonary arterial hypertension (WHO Group 1), to improve exercise capacity.Limitations. This claim records what one US label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. Contraindications, other warnings, interactions and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care. The label also lists improving WHO functional class and delaying clinical worsening; only the exercise capacity wording is quoted here.
-
Claim, not a settled fact Evaluated for this: Treprostinil
Applies to Recipient not specified Patients with pulmonary hypertension associated with interstitial lung disease, as described in the US label of Tyvaso
Population, setting and follow-up
- Patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3), as the label states. The passage read gives no age range.
- Prescription medicine, as described in the US label
- United States (label of the US Food and Drug Administration)
- Not stated in the passage read
- Gestational age Not reported
- Postnatal age Not reported
The same US label of Tyvaso separately lists treating pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability.Limitations. This claim is tied to the Tyvaso inhalation solution label only, and concerns a different group of pulmonary hypertension from pulmonary arterial hypertension. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care. Contraindications, warnings, interactions and dosing were not recorded, and no trial result is recorded for the statement.
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 104
Record details
- Record id
cardio:pulmonary-hypertension- Content hash
0548242ae2463c9580d9c7f2f814d4b08630b91f663ad91bc6f267f8e80abee4